United Therapeutics | UTHR - Операционный доход





Операционный доход Изменить Дата
Amarin USD -2.26M 564K 2025-12
Ardelyx USD -32.79M 37.89M 2026-03
Baxter International USD 276M 210M 2026-06
Bayer EUR 827M 2.7B 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD -243.8M 758.1M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Emergent BioSolutions USD -218M 69.9M 2023-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Insmed USD -101.31M 98.97M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
J&J USD 7.48B 860M 2026-06
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Moderna USD -815M 573M 2026-06
Omeros USD -35.41M 23.75M 2024-09
Pfizer USD 667M 4.32B 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Teva Pharmaceutical Industries USD 235M 523M 2026-06
United Therapeutics USD 330.8M 5M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06